Silk Road Medical stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 80 to 92.
As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength. This exclusive rating from Investor's Business Daily identifies price action with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating of at least 80 at the beginning of a new run.
Looking For Winning Stocks? Try This Simple Routine
Is Silk Road Medical Stock A Buy?
Silk Road Medical stock is building a consolidation with a 50.01 entry. See if the stock can clear the breakout price in volume at least 40% higher than normal. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The medical device maker showed -38% EPS growth in its most recent report, while sales growth came in at 25%.
Silk Road Medical stock holds the No. 31 rank among its peers in the Medical-Products industry group. Lantheus, Meridian Bioscience and Resmed are among the top 5 highly rated stocks within the group.
